Researchers at the San Diego Supercomputer Center (SDSC) and the Moores Cancer Center at the University of California, San Diego, have described for the first time the molecular
mechanism of cancer development caused by well - known «resistance» mutations in the gene called epidermal growth factor receptor (EGFR).
Not exact matches
These results have important implications for the understanding
of the
mechanisms controlling tumour heterogeneity and the
development of new strategies to block PIK3CA induced breast
cancer.
The Cent - 1 molecule kills
cancer cells through a
mechanism similar to that
of the template drug Rigosertib that is currently under commercial
development.
«We've long known that NF - kB promotes
cancer development by subverting apoptosis, an internal safety
mechanism that otherwise would cause
cancer cells to self - destruct,» says principal investigator Denis Guttridge, PhD, professor
of molecular virology, immunology and medical genetics and
of molecular and cellular biochemistry.
Although proteasome inhibitors are very efficient in selective killing
of cancer tumor cells grown in a dish (in - vitro), their success in the clinic has largely been undermined by the
development of resistance —
mechanisms of which are poorly understood.
A better understanding
of the
mechanism that accelerates or restricts the
development of cancer may allow, for example, the discovery
of new biomarkers to better identify the population at greatest risk
of colon
cancer and even the current degree
of risk.
Along with finding that the tumor suppressor protein SIRT6 is inactive in around 30 percent
of cases
of pancreatic ductal adenocarcinoma (PDAC), the team identified the precise pathway by which SIRT6 suppresses PDAC
development, a
mechanism different from the way it suppresses colorectal
cancer.
The work published in
Cancer Cell complements previous research efforts from the CNIO Melanoma Group, which could lead to the
development of novel drugs that selectively target the
mechanism of cell autodigestion as a potential therapeutic strategy.
These techniques are key to understanding the molecular
mechanisms underlying cell function in healthy and diseased individuals and the
development of diseases like
cancer.
Genotoxicity is associated with the
development of diseases and is a critical
mechanism responsible for many types
of cancer caused by smoking and secondhand smoke exposure.
The molecular
mechanisms involved in the
development of cancer have been uncovered by extensive research over the past 30 years, culminating in The Cancer Genome Atlas, a National Institutes of Health project that identified and characterized many genetic mutations that fuel c
cancer have been uncovered by extensive research over the past 30 years, culminating in The
Cancer Genome Atlas, a National Institutes of Health project that identified and characterized many genetic mutations that fuel c
Cancer Genome Atlas, a National Institutes
of Health project that identified and characterized many genetic mutations that fuel
cancercancer.
She is investigating the role
of glycosylated molecules in tumor progression and metastasis, tissue - and species - specific expression
of lectin receptors that play a role in regulating host innate immune responses and inflammation, and the immunological
mechanisms underlying chronic inflammation and
cancer development.
In this way our study took a very different approach as we have used chemistry to mimic genetic
mechanisms that are able to block the
development of Ras - dependent
cancers.»
But University
of California San Diego School
of Medicine researchers have now found that chronic liver inflammation also promotes
cancer by suppressing immunosurveillance — a natural defense
mechanism in which it's thought the immune system suppresses
cancer development.
In the absence
of this and other defense
mechanisms, Weinberg says, «
cancer development would be inevitable, and we would be covered by tumors by the time we're several years old.»
And with non-melanoma skin
cancers being the most frequent human tumors, there is clearly a tremendous need to understand the underlying molecular
mechanisms, to allow the
development of drugs to treat these types
of cancer.
The research indicates that a contribution
of EBV to the
development of breast
cancer is plausible, through a
mechanism in which EBV infection predisposes MECs to become malignant but is no longer required once the cells have become cancerous.
The study also may have broader implications for how clinicians approach the
development of such treatments and understand
mechanisms behind resistance to treatment in other
cancers.
The «small, but perfectly formed» flies will help scientists sort out the
mechanisms governing cell size and number during
development, says molecular biologist Sally Leevers
of the Ludwig Institute for
Cancer Research in London.
No previous studies have investigated the direct effect
of sugar consumption on the
development of breast
cancer using breast
cancer animal models or examined specific
mechanisms, she added.
«Our research reveals a new regulatory
mechanism that coordinates two distinct intracellular processes that are critical to cellular homeostasis and disease
development,» said Chengyu Liang, M.D., Ph.D., a member
of the USC Norris Comprehensive
Cancer Center and principal investigator
of the study.
The research could aid in the
development of new drugs that use a similar
mechanism as melittin's to attack
cancer and bacteria.
These include, for example, the
mechanisms behind stem - cell
development and what happens when normal cellular growth spirals out
of control, such as in
cancer.
Published in the May 1 edition
of Cancer Research, the study supports a critical role for IGF - 1R signaling in prostate - tumor
development and identifies an important IGF - 1R - dependent growth control
mechanism, according to the authors.
Using mouse models that replicate the complexity
of human hepatocellular carcinoma genetics, he is working on unravelling the
mechanisms of regeneration and
cancer development in the liver.
Cellular
mechanisms and molecular regulation
of epithelial morphogenesis in
development and
cancer.
Many
cancers are still difficult to treat and
development of drugs exploiting new pathways and
mechanisms involved in tumor initiation and malignant growth is
of high priority [1].
Dr. Orkin's research focuses on the
development and function
of the blood system, the relationship between
cancer and stem cells, and the
mechanisms responsible for self - renewal
of stem cells.
His group is are studying the
mechanism of stable inherited epigenetic transcriptional repression by Polycomb - group (Pc - G) protein complexes, and the effects
of deregulation
of Pc - G genes on Homeobox gene expression,
development, Cell cycle control and
cancer formation.
Her work in the COBRE for
Cancer Research and
Development has traced the molecular
mechanisms underlying the effect
of a pathway called mTOR.
To cite a few instances, polymerase chain reaction (PCR), a molecular method developed over three decades ago, has been widely applied in disease diagnosis, disease
mechanism deciphering, and prognosis prediction; the elucidation
of tyrosine kinase activity in
cancer cells has led to the
development of novel drugs for
cancer treatment; and the identification
of proteins and genetic molecules by molecular methods as biomarkers for disease diagnosis and prognosis has been drawing great interest.
Mechanisms that link tumor suppression and the
development of cancer to aging and the major diseases associated with aging
Our ultimate goals in this activity include (1) a better understanding
of the molecular
mechanisms governing cellular processes and especially those involved in certain kinds
of diseases such as
cancer and (2) the
development of computational tools that can be used for diagnostic / prognostic purposes based on genomic data.
The mission
of the Institute for Applied
Cancer Science (IACS) is to apply scientific knowledge of mechanisms driving tumor development and maintenance into the development of impactful small molecule cancer ther
Cancer Science (IACS) is to apply scientific knowledge
of mechanisms driving tumor
development and maintenance into the
development of impactful small molecule
cancer ther
cancer therapies.
She is registred to the National Order
of Biologists in the province
of Palermo; collaboration in research project from 2012 to 2015 at the Department
of Biopathology and Biotechnology, University
of Palermo, focusing the study on the identification
of molecules capable to modulate intracellular metabolic pathways for the prevention and treatment
of infectious, tumor and degenerative disease, in collaboration with Prof. Angela Santoni, University
of Rome; collaboration in research project in 2011 at the hospital «Villa Sofia Cervello»
of Palermo to study methods can cure the genetic defect that causes thalassemia through genetic engineering; she studies different
mechanisms of the differentiation and the activation
of human gammadelta T cells as effector cells
of the immune response against
cancer and infectious diseases; she investigates about the identification and
development of biomarkers
of resistance and susceptibility to Mycobacterium tuberculosis infection; Valentina Orlando has published 13 papers in peer reviewed journals and 3 comunications at national and international congress.
Areas covered by
Cancer Cell include, but are not limited to, molecular and cellular mechanisms of cancer, mechanisms for the sensitivity and the resistance to cancer therapies, and development of better cancer ther
Cancer Cell include, but are not limited to, molecular and cellular
mechanisms of cancer, mechanisms for the sensitivity and the resistance to cancer therapies, and development of better cancer ther
cancer,
mechanisms for the sensitivity and the resistance to
cancer therapies, and development of better cancer ther
cancer therapies, and
development of better
cancer ther
cancer therapies.
Helicobacter pylori effector protein CagA activates the signal transduction and activator
of transcription 3 (STAT3) signaling pathway: a potential
mechanism for gastric
cancer development.
Hu's research interests include the analysis
of the
mechanisms of B cell
development and B cell
cancer formation.
My studies
of cancer genomes have led to characterization
of multiple pediatric and adult tumor types, to
development of methods that identify and characterize changes in genomic heterogeneity, to defining acquired resistance
mechanisms to targeted therapies and to designing novel, personalized vaccines for individual patients.
Facilitate cross-disciplinary research programs focused on understanding the biological
mechanisms of lymphoid
cancers for the
development of novel therapeutic treatments for these
cancers.
Collectively, their work has elucidated foundational
mechanisms in
cancer's ability to evade immune recognition and, in doing so, has profoundly altered the understanding
of disease
development and treatment.
Researchers are now studying the molecular
mechanisms and signaling pathways
of cancer cell
development, proliferation, and metastasis.
Dr. Macara studies the
development of the ducts that form breast tissue, and the
mechanisms that can result in the initiation and spread
of breast
cancer.
Other publications on
cancer chemoprevention include Comprehensive review of cancer chemopreventive agents evaluated in experimental carcinogenesis models and clinical trials, Chemopreventive effects of natural dietary compounds on cancer development, Organosulfur compounds in cancer chemoprevention, Cancer prevention by natural compounds, Cruciferous vegetables and cancer prevention, Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis, Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and sel
cancer chemoprevention include Comprehensive review
of cancer chemopreventive agents evaluated in experimental carcinogenesis models and clinical trials, Chemopreventive effects of natural dietary compounds on cancer development, Organosulfur compounds in cancer chemoprevention, Cancer prevention by natural compounds, Cruciferous vegetables and cancer prevention, Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis, Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and sel
cancer chemopreventive agents evaluated in experimental carcinogenesis models and clinical trials, Chemopreventive effects
of natural dietary compounds on
cancer development, Organosulfur compounds in cancer chemoprevention, Cancer prevention by natural compounds, Cruciferous vegetables and cancer prevention, Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis, Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and sel
cancer development, Organosulfur compounds in
cancer chemoprevention, Cancer prevention by natural compounds, Cruciferous vegetables and cancer prevention, Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis, Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and sel
cancer chemoprevention,
Cancer prevention by natural compounds, Cruciferous vegetables and cancer prevention, Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis, Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and sel
Cancer prevention by natural compounds, Cruciferous vegetables and
cancer prevention, Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis, Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and sel
cancer prevention, Cruciferous vegetables and human
cancer risk: epidemiologic evidence and mechanistic basis, Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and sel
cancer risk: epidemiologic evidence and mechanistic basis, Cruciferous vegetables:
cancer protective mechanisms of glucosinolate hydrolysis products and sel
cancer protective
mechanisms of glucosinolate hydrolysis products and selenium.
No previous studies have investigated the direct effect
of sugar consumption on the
development of breast
cancer using breast
cancer animal models or examined specific
mechanisms, she added.
Studies have shown that herpes is with the changes in breast
cancer and the continuous
development of cancer cells in the deepening
of the
mechanism of infection continue to occur malignant deformation.